CAS NO: | 76135-31-4 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | 8-OH-DPAT (8-Hydroxy-DPAT) hydrobromide is a potent and selective5-HT1Aagonist with apIC50of 8.19. 8-OH-DPAT hydrobromide has selectivity of almost 1000 fold for a subtype of the 5-HT1binding site[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | 8-OH-DPAT (8-Hydroxy-DPAT) hydrobromide has no effect on 5-HT1Bbinding at concentrations lower than 100 nM[1]. | ||||||||||||||||
体内研究 (In Vivo) | 8-OH-DPAT (8-Hydroxy-DPAT) hydrobromide (32, 56, 80, 100 mg/kg; intramuscularly; 15 min prior to the testing session) of the highest dose significantly interferes with sustained attention and reinforcer efficacy (progressive ratio; PR) performance in the 3,4-methylenedioxymethamphetamine (MDMA)-exposed but not control animals[1]. | ||||||||||||||||
分子量 | 328.29 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C16H26BrNO | ||||||||||||||||
CAS 号 | 76135-31-4 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 25 mg/mL(76.15 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |